Dr. Nadia Giannetti trained at McGill and Stanford University. She is an attending Cardiologist and an Associate Professor at McGill. She is the Medical Director of the Heart Failure and Transplant Program at the MUHC. She is a co-author of several Canadian Heart Failure and Heart Transplant Guidelines. She has led multiple clinical trials as a local PI. She is the former Chief of Cardiology and is presently the Associate Physician-in-Chief (Department of Medicine) at the MUHC.

Natalie Gendron is the lead research nurse for the Courtois Cardiovascular Signature clinical team and Project Manager for Heart-in-a-Dish protocol. She has been involved in multiple cardiovascular clinical trials with pharmaceuticals as well as local investigators. She is involved in patient recruitment, data capture and the liaison with Dr. Cecere and Dr. Hebert’s research teams.

Leila Haririsanati is a clinical research coordinator and MD from Iran. She is passionate about patient care. She approaches people with kindness, recruits patients and collects samples for the protocol.

Dr. Hébert has a long track record in understanding the biology of key signalling proteins in cardiovascular disease. His lab’s new focus on induced pluripotent stem cells iPSCs for DCM disease modelling has opened productive new vistas for their work to understand disease progression in individual patients.

Kyla’s research focuses on exploring cellular signalling in health and disease using iPSC-derived cardiomyocytes derived from healthy volunteers and patients diagnosed with idiopathic dilated cardiomyopathy.

Dr. Sonya Hui is a Cardiology resident physician at McGill University. She completed her MSc and PhD at the University of Toronto and postdoctoral fellowship at the University of Ottawa Heart Institute in cardiovascular scientific research. Her academic interests include translational cardiovascular research and personalized medicine.

Dr. Cecere is a cardiac surgeon at the McGill University Health Centre and his research program focuses on the prevention of cardiac disease and cardiac repair. His laboratory’s work involves studying cell-free therapies, elucidating personalized treatments for patients with heart disease, as well as gaining a better understanding of the underlying causes of patient-specific responses to injury.

Natalie Gendron is the lead research nurse for the Courtois Cardiovascular Signature clinical team and Project Manager for Heart-in-a-Dish protocol. She has been involved in multiple cardiovascular clinical trials with pharmaceuticals as well as local investigators. She is involved in patient recruitment, data review and the liaison with Dr. Cecere and Dr. Hebert’s research teams.

Alex Cai, Medical Student at McGill University BSc, Honours Anatomy and Cell Biology. His work in Dr. Terry Hébert’s lab focuses on improving individualized heart disease modelling using 3D cardiac organoids

Nadya Kachurina is a brilliant and insightful Technician in Dr. Cecere’s laboratory. She is responsible for the validation of iPSC patient lines using state of the art techniques in trilineage assays, immunohistochemistry and karyotyping.

Ludovic is a Master’s student in Dr. Cecere’s lab who has been trained in iPSC and Cardiomyocyte work. His research focuses on investigating patient sensitivity in response to Doxorubicin, a powerful chemotherapeutic which has cardiotoxic side effect, leading to heart failure.

Dr. Mehran Mottahedi is an MD and current MSc student at McGill University, specializing in iPSC-derived cardiomyocyte research and proteomics analysis. His work focuses on using advanced proteomics techniques to identify specific plasma protein biomarkers for early detection, prognosis, and classification of dilated cardiomyopathy. ”

Ali Mousavi is a Post Doctoral Fellow in Dr. Cecere’s lab working on modeling dilated cardiomyopathy in a 3D heart-on-a-chip platform using patient-specific hiPSC-cardiomyocytes to create beating heart tissues in vitro. His research aims to understand the disease mechanisms and enable personalized medicine approaches for drug discovery and screening applications

Bryan Lung is a master’s student at McGill University working under Dr. Cecere’s supervision. His research interest focuses on elucidating the patient-specific differences in dilated cardiomyopathy pathology and the differential molecular mechanisms observed in patient derived iPSC-cardiomyoycte cell lines by using single-cell RNA sequencing technology.

Dr. Yasaman Hekmatnia is a medical doctor and is currently pursuing a master’s degree and conducting research at McGill University. Her interests focus on lipid and redox profiles in plasma and iPSC-derived cardiomyocytes. Yasaman’s research concentrates on identifying biomarkers and developing innovative therapeutic strategies for dilated cardiomyopathy.

Dr. Nadia Giannetti trained at McGill and Stanford University. She is an attending Cardiologist and an Associate Professor at McGill. She is the Medical Director of the Heart Failure and Transplant Program at the MUHC. She is a co-author of several Canadian Heart Failure and Heart Transplant Guidelines. She has led multiple clinical trials as a local PI. She is the former Chief of Cardiology and is presently the Associate Physician-in-Chief (Department of Medicine) at the MUHC.

Diego Loggia is a PhD student using iPSC-derived cardiomyocytes to evaluate novel mechanisms and risk factors underlying doxorubicin-induced dilated cardiomyopathy, and to determine optimal patient-specific treatment strategies for the disease.

Jana Schuettpelz obtained her PhD in the department of Human Genetics at McGill studying the function of a mitochondrial protein. As a post-doctoral fellow in Dr. Hébert’s lab, she is involved in generating cardiomyocytes from patient-derived stem cells and characterizing these.

Giada  is a master’s student focused on understanding morphological and signalling differences between dilated cardiomyopathy patients and controls by using iPSC-derived cardiomyocytes and cardiac organoids.

Leila Haririsanati is a clinical research coordinator and MD from Iran. She is passionate about patient care. She approaches people with kindness, recruits patients and collects samples for the protocol.

Dr. Hébert has a long track record in understanding the biology of key signalling proteins in cardiovascular disease. His lab’s new focus on induced pluripotent stem cells iPSCs for DCM disease modelling has opened productive new vistas for their work to understand disease progression in individual patients.

Kyla’s research focuses on exploring cellular signalling in health and disease using iPSC-derived cardiomyocytes derived from healthy volunteers and patients diagnosed with idiopathic dilated cardiomyopathy.

Dr. Sonya Hui is a Cardiology resident physician at McGill University. She completed her MSc and PhD at the University of Toronto and postdoctoral fellowship at the University of Ottawa Heart Institute in cardiovascular scientific research. Her academic interests include translational cardiovascular research and personalized medicine.

Dr. Cecere is a cardiac surgeon at the McGill University Health Centre and his research program focuses on the prevention of cardiac disease and cardiac repair. His laboratory’s work involves studying cell-free therapies, elucidating personalized treatments for patients with heart disease, as well as gaining a better understanding of the underlying causes of patient-specific responses to injury.

Natalie Gendron is the lead research nurse for the Courtois Cardiovascular Signature clinical team and Project Manager for Heart-in-a-Dish protocol. She has been involved in multiple cardiovascular clinical trials with pharmaceuticals as well as local investigators. She is involved in patient recruitment, data review and the liaison with Dr. Cecere and Dr. Hebert’s research teams.

Alex Cai, Medical Student at McGill University BSc, Honours Anatomy and Cell Biology. His work in Dr. Terry Hébert’s lab focuses on improving individualized heart disease modelling using 3D cardiac organoids

Nadya Kachurina is a brilliant and insightful Technician in Dr. Cecere’s laboratory. She is responsible for the validation of iPSC patient lines using state of the art techniques in trilineage assays, immunohistochemistry and karyotyping.

Ludovic is a Master’s student in Dr. Cecere’s lab who has been trained in iPSC and Cardiomyocyte work. His research focuses on investigating patient sensitivity in response to Doxorubicin, a powerful chemotherapeutic which has cardiotoxic side effect, leading to heart failure.

Dr. Mehran Mottahedi is an MD and current MSc student at McGill University, specializing in iPSC-derived cardiomyocyte research and proteomics analysis. His work focuses on using advanced proteomics techniques to identify specific plasma protein biomarkers for early detection, prognosis, and classification of dilated cardiomyopathy. ”

Ali Mousavi is a Post Doctoral Fellow in Dr. Cecere’s lab working on modeling dilated cardiomyopathy in a 3D heart-on-a-chip platform using patient-specific hiPSC-cardiomyocytes to create beating heart tissues in vitro. His research aims to understand the disease mechanisms and enable personalized medicine approaches for drug discovery and screening applications

Bryan Lung is a master’s student at McGill University working under Dr. Cecere’s supervision. His research interest focuses on elucidating the patient-specific differences in dilated cardiomyopathy pathology and the differential molecular mechanisms observed in patient derived iPSC-cardiomyoycte cell lines by using single-cell RNA sequencing technology.

Dr. Yasaman Hekmatnia is a medical doctor and is currently pursuing a master’s degree and conducting research at McGill University. Her interests focus on lipid and redox profiles in plasma and iPSC-derived cardiomyocytes. Yasaman’s research concentrates on identifying biomarkers and developing innovative therapeutic strategies for dilated cardiomyopathy.

Dr. Nadia Giannetti trained at McGill and Stanford University. She is an attending Cardiologist and an Associate Professor at McGill. She is the Medical Director of the Heart Failure and Transplant Program at the MUHC. She is a co-author of several Canadian Heart Failure and Heart Transplant Guidelines. She has led multiple clinical trials as a local PI. She is the former Chief of Cardiology and is presently the Associate Physician-in-Chief (Department of Medicine) at the MUHC.

Diego Loggia is a PhD student using iPSC-derived cardiomyocytes to evaluate novel mechanisms and risk factors underlying doxorubicin-induced dilated cardiomyopathy, and to determine optimal patient-specific treatment strategies for the disease.

Jana Schuettpelz obtained her PhD in the department of Human Genetics at McGill studying the function of a mitochondrial protein. As a post-doctoral fellow in Dr. Hébert’s lab, she is involved in generating cardiomyocytes from patient-derived stem cells and characterizing these.

Giada  is a master’s student focused on understanding morphological and signalling differences between dilated cardiomyopathy patients and controls by using iPSC-derived cardiomyocytes and cardiac organoids.

Leila Haririsanati is a clinical research coordinator and MD from Iran. She is passionate about patient care. She approaches people with kindness, recruits patients and collects samples for the protocol.